UPC_CFI_616/2025

LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

VerletzungHauptverletzungsklageThe Hague LDInfringementWritten Phase

2026-02-18Nur prozessualproceduralInfringement Action
The Hague Local Division ruled on GSK's application to amend its claim under Rule 263 RoP and Moderna's application to dismiss late-filed submissions under Rule 9 RoP in patent infringement proceedings relating to mRNA vaccine technology.